Boost cancer prevention and survival through Asian nutritional diet

Precision technology empowers early detection for improved patient outcomes

Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.

With five specialty practices under one roof, patients experience optimal care with maximum convenience at the Providence Advanced Care Center.

In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.

The Providence Cancer Center is hosting an event to help raise awareness about colorectal cancer 11 a.m.-1 p.m. Tuesday, March 26, in the Providence Health Park.

In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.

In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.

Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.

The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).

Supporting thousands of patients experiencing food insecurity, a converted space at Providence Gateway Internal Medicine clinic is filled with fresh fruits and vegetables, meat, milk, eggs and more.

​​​​​​​Providence Saint Joseph Medical Center has opened a Multi-Cancer Early Detection Clinic, the first of its kind in the San Fernando Valley.

Jamie Zilverberg, MSN, FNP, AOCNP, receives the prestigious 2024 Values in Action Award, the highest honor given at Providence St. Joseph Health.

The Ion Robotic Bronchoscopy System, a new surgical technology, is improving early screening, detection and treatment of lung cancer – which means a better chance of survival.

Providence registered dietitian Christina Speaks, MS, RDN, LD, shares valuable information about food and common cancer myths.

New study evaluates immunotherapy in combination with other medications in people with endometrial cancer, and a phase I trial for people with AML assesses a non-engineered natural killer cell therapy

"Within Reach: The Fight to Finish Cancer" follows patient participants and teams of researchers and clinicians at Providence Cancer Institute working to create a living drug for incurable cancers.

New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.